Lily Allen Has A Third Nipple?

…and she exposed it for an interviewer?

…and it was a television interview!?

…and she admitted that “it gets hard when you touch it?”

Yes, yes, yes, yes.

Video here.

And in case you missed it, Lily’s cover of  “Womanizer” (Brit-Brit cover).

Brit-Brit & Madge: Year 2019!

Fox News has some ridiculous age-extrapolated photos of  Britney Spears and Madonna:

Sorry, it was too ridiculous not to share.

Deal: WB To Proceed With Release of “Watchmen”

The unprecedented legal dispute that  could have delayed or prevented the release of a movie that had already been completely finished has been settled.  Fox agreed to a percentage of the box office revenue the WB-made “Watchmen” makes as well as a revenue cut from any sequels or spin-offs in exchange for letting WB release the picture, as planned, on March 6.

According to all the buzz, this is supposed to be, like, the greatest comic book graphic novel that has ever  been ever made ever.  I’m completely confident the movie will live up to all this hype and, if not, at least there are ripped, naked, blue dudes. 

The Daily Beast has background on the film and Variety has the details of the of the settlement.

Trailer:

Failblog: Extra Fresh Sperm!

Via Failblog.

Eli Lilly To Pay $1.4B To Settle CRIMINAL Charges

The drug company Eli Lilly has settled civil and criminal charges lodged against the company for the marketing of it’s top-selling drug Zyprexa.  The drug was approved in 1996 only for use with severe schizophrenia and a specific type of bipolar disorder.  However, Lilly purposefully marketed the drug to “two categories of patients — children and the elderly — for whom the drug was not federally approved and in whom its use was especially risky” (NY Times, emphasis mine).  In it’s peddling of the drug to geriatricians, the company used the slogan “5 [mg] at 5 [o'clock]” to promote the drug’s ability to sedate the elderly into a state that would require less attention from those caring for them.

Unfortunately, all of this off-label use of Zyprexa was particularly dangerous since the drug “increases the risks of sudden death, heart failure and life-threatening infections like pneumonia in elderly patients with dementia-related psychosis” (NY Times).  Oh, and for those poor children given the drug, they faced severe weight-gain and metabolic disorders, like diabetes.  Yay!

Lilly made $1.19B from Zyprexa in the third quarter alone (CBS News) and it’s been estimated the drug has pulled-in $37B (CNN Money) since they started selling it in 1996, so I can’t help to think that $1.4B is kind of a drop in the bucket.  I would like to think that the fact that their actions reached the criminal threshold would have some impact on their professional reputation but as long as they find another, new wonder drug that can produce good quarterly earnings for their stockholders, I doubt this will have any lasting impact.

Sources and further reading: NY Times; CBS News; CNN Money.

Trivia: Correct me if I’m wrong, but I believe the United States is the only country with direct-to-consumer marketing of drugs that require a doctor’s prescription.

Related: There was a highly-enlightening article in the Times in November 2007 about Wyeth’s marketing of Effexor XR, a drug that was originally marketed as the most effective SSRI available.  (A monumental claim, since the SSRI market is so expansive/lucrative.)  Unfortunately, Wyeth was lying about the efficacy of the drug and down-playing the side effects (like, oh, seizures) they knew existed.  The article follows one professional as he becomes a represenatative for Wyeth – a very profitable venture – and begins to peddle these falsehoods.  It’s a great read and I’d highly recommend it.  NY Times: Dr. Drug Rep.